Generalised anxiety disorder, depressive symptoms and their subjective change after the first wave of COVID-19 among gamers in Poland.

COVID-19 Depression Gamers General anxiety

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 20 09 2022
revised: 23 05 2023
accepted: 31 05 2023
medline: 8 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Previous studies have indicated that levels of emotional distress were considerably elevated during the COVID-19 pandemic; however, some longitudinal studies did not confirm these findings. There is a very limited number of studies on specific subpopulations, such as video gamers in this particular period. Playing video games may have either a beneficial influence on mental health by diminishing stress or a detrimental impact in terms of increasing depression and anxiety. It is, therefore, important to establish whether regular gamers differ from the general population in terms of symptoms of depression and anxiety during COVID-19. A total of 1023 participants (aged 18-50) participated in the study. The sample was composed of gamers and was representative of the Polish population. Participants completed a modified version of GAD-7, PHQ-9 online, addressing subjective change in anxiety and depressive symptoms. 25% of the sample reported clinically significant anxiety levels, and 35% mentioned depression. There were no differences in anxiety and depression levels between the investigated sample of gamers and the general population. However, up to 30% of individuals reported an increase in subjective change in anxiety or depressive symptoms during COVID-19. A further 30% reported a downward subjective change in anxiety or depressive symptoms during COVID-19. The remaining 40% declared a lack of change in the subjective change in anxiety or depressive symptoms during COVID-19. Those who reported an increase scored substantially higher in anxiety and depression than other groups. This indicates that the COVID-19 pandemic may have impacted people's mental health along a syndemic-syndaimonic continuum. COVID-19 might have been harmful to those with already poorer mental health and beneficial to those with good mental health. It is also important to plan interventions targeting vulnerable individuals who report clinically significant levels of anxiety and depression - women and younger adults and those who subjectively perceive their emotional condition to deteriorate during the COVID-19 lockdown.

Identifiants

pubmed: 37287608
doi: 10.1016/j.heliyon.2023.e16894
pii: S2405-8440(23)04101-4
pmc: PMC10234366
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e16894

Informations de copyright

© 2023 The Author.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Affect Disord. 2003 Mar;74(1):5-13
pubmed: 12646294
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Psychiatry Res. 2020 Jul;289:113098
pubmed: 32434092
Cad Saude Publica. 2020 Apr 30;36(4):e00054020
pubmed: 32374806
J Affect Disord. 2021 May 1;286:296-300
pubmed: 33756307
NCHS Data Brief. 2020 Sep;(378):1-8
pubmed: 33054928
Compr Psychiatry. 2020 Jul;100:152180
pubmed: 32422427
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
JMIR Serious Games. 2022 Jan 25;10(1):e33059
pubmed: 34817386
Annu Rev Psychol. 2004;55:745-74
pubmed: 14744233
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
J Behav Addict. 2017 Dec 1;6(4):516-524
pubmed: 29130328
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Behav Addict. 2020 Apr 29;9(2):184-186
pubmed: 32352927
JAMA Intern Med. 2020 Jun 1;180(6):817-818
pubmed: 32275292
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
NCHS Data Brief. 2020 Sep;(379):1-8
pubmed: 33054920
Am Psychol. 2021 Jan;76(1):50-62
pubmed: 32700938
J Affect Disord. 2020 Dec 1;277:75-84
pubmed: 32799107
Med Anthropol Q. 2016 Dec;30(4):462-478
pubmed: 25865829
J Affect Disord. 2020 Dec 1;277:842-849
pubmed: 33065825
Games Health J. 2020 Aug;9(4):255-264
pubmed: 32053021
Addict Behav. 2021 Dec;123:107044
pubmed: 34311186
Clin Neuropsychiatry. 2021 Feb;18(1):65-74
pubmed: 34909021
Int J Ment Health Addict. 2021;19(6):2369-2382
pubmed: 32837421
Soc Sci Med. 2022 Feb;295:114656
pubmed: 34949486
J Med Internet Res. 2020 Dec 24;22(12):e22740
pubmed: 33320824
BMJ. 1995 Feb 4;310(6975):298
pubmed: 7866172
Compr Psychiatry. 2021 Feb;105:152222
pubmed: 33388494
Lancet. 2017 Mar 4;389(10072):978-982
pubmed: 28271848
Front Psychol. 2020 Jul 21;11:1465
pubmed: 32848970
Soc Psychiatry Psychiatr Epidemiol. 2008 Dec;43(12):983-98
pubmed: 18575787
Cyberpsychol Behav Soc Netw. 2022 Jun;25(6):334-354
pubmed: 35639118
J Gen Intern Med. 2007 Nov;22(11):1596-602
pubmed: 17874169
BMC Psychiatry. 2019 Sep 18;19(1):291
pubmed: 31533674
PLoS One. 2020 Jul 28;15(7):e0236562
pubmed: 32722711
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Lancet Psychiatry. 2020 Mar;7(3):e14
pubmed: 32035030
J Med Internet Res. 2020 Dec 22;22(12):e25117
pubmed: 33284781
Nature. 1998 May 21;393(6682):266-8
pubmed: 9607763
Compr Psychiatry. 2019 Oct;94:152117
pubmed: 31422185
Lancet. 2017 Mar 4;389(10072):941-950
pubmed: 28271845
Cyberpsychol Behav. 2006 Dec;9(6):772-5
pubmed: 17201605
BMJ Open. 2020 Nov 24;10(11):e042696
pubmed: 33234659
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Lancet Psychiatry. 2021 Feb;8(2):141-149
pubmed: 33308420
Acta Psychiatr Scand. 2020 Sep;142(3):249-256
pubmed: 32716520
PLoS One. 2021 Nov 24;16(11):e0259013
pubmed: 34818330
Psychiatry Res. 2020 Jun;288:112954
pubmed: 32325383
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):283-291
pubmed: 32691135
Compr Psychiatry. 2020 Oct;102:152192
pubmed: 32688022
Psychiatry Res. 2020 Jun;288:112992
pubmed: 32302816
J Affect Disord. 2020 Sep 1;274:576-582
pubmed: 32663990
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
Soc Sci Med. 2022 Feb;295:112728
pubmed: 31879045
Behav Res Methods. 2011 Sep;43(3):814-25
pubmed: 21487899
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Psychiatry Res. 2020 Nov;293:113396
pubmed: 32861096
J Psychopathol Behav Assess. 2017 Mar;39(1):140-146
pubmed: 28260835
Am Psychol. 2021 Apr;76(3):427-437
pubmed: 32744841

Auteurs

Magdalena Rowicka (M)

Maria Grzegorzewska University, Institute of Psychology, Szczesliwicka 40, 02-353 Warsaw, Poland.

Classifications MeSH